Five Prime Therapeutics, Inc. FPRX
— —
Day range unavailable
52-week range unavailable
News
prnewswire.com Amgen Successfully Completes Acquisition Of Five Prime Therapeutics THOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares…
gurufocus.com Prime Time's Revival a Lesson for Biotech Investors In Amgen Inc.'s (NASDAQ:AMGN) recent agreement to buy small cancer drug developer Five Prime Therapeutics Inc. (NASDAQ:FPRX) for nearly $2 billion, there seems to be a message for investors in other…
benzinga.com Though Potential Bidders Moved Away, Amgen's Bid For Five Prime Outlasted 15 Suitors Earlier this month, biotech giant Amgen Inc (NASDAQ: AMGN) announced a $1.9 billion buyout of Five Prime Therapeutics Inc (NASDAQ: FPRX) that outlasted around 15 potential collaborators. Background:…
benzinga.com Earnings Scheduled For March 10, 2021 Companies Reporting Before The Bell • BioDelivery Sciences Intl (NASDAQ:BDSI) is estimated to report quarterly earnings at $0.06 per share on revenue of $38.72 million.
businesswire.com Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call
zacks.com Why Five Prime Therapeutics (FPRX) Might Surprise This Earnings Season Five Prime Therapeutics (FPRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
prnewswire.com SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Five Prime Therapeutics, Inc. - FPRX NEW YORK, March 5, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class…
zacks.com Five Prime Therapeutics (FPRX) Stock Jumps 78.7%: Will It Continue to Soar? Five Prime Therapeutics (FPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further…
benzinga.com 82 Biggest Movers From Yesterday Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 78.7% to close at $38.00 on Thursday after Amgen announced plans to acquire the company for $1.9 billion.
pulse2.com FPRX Stock Price Increases 78.74% On Amgen Acquisition News The stock price of Five Prime Therapeutics Inc (NASDAQ: FPRX) increased by 78.74% today. This is why it happened.
prnewswire.com SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc. NEW YORK, March 4, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Five Prime Therapeutics, Inc. ("Five…
prnewswire.com Shareholder Alert: Ademi LLP Investigates whether Five Prime Therapeutics has obtained a Fair Price in its transaction with Amgen MILWAUKEE, March 4, 2021 /PRNewswire/ -- Ademi LLP is investigating Five Prime (NASDAQ: FPRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Amgen. Click…
fool.com Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion The big biotech wants to bolster its late-stage pipeline with a potential new stomach cancer treatment.
fool.com Why Five Prime Therapeutics Stock Is Skyrocketing Today Amgen is paying a premium to buy the small biotech.
investorplace.com FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher Five Prime Therapeutics (FPRX) stock is soaring higher on Thursday following news that Amgen (AMGN) is acquiring the company. The post FPRX Stock: The Huge Takeover News That Has Five Prime…
benzinga.com Amgen Pays $1.9B For Five Prime Therapeutics Acquisition Amgen Inc (NASDAQ: AMGN) has agreed to acquire Five Prime Therapeutics Inc (NASDAQ: FPRX) for $38 per share in cash, representing an equity value of approximately $1.9 billion. The offer price of $38…
benzinga.com Stocks That Hit 52-Week Highs On Thursday Thursday's morning session saw 237 companies set new 52-week highs.
businesswire.com Five Prime Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Five Prime Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FPRX NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Five Prime Therapeutics, Inc. (NASDAQ: FPRX) to Amgen Inc. for $38.00 per share in…
marketwatch.com Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio Amgen Inc. announced Thursday an agreement to buy biotechnology company Five Prime Therapeutics Inc. in a cash deal valued at $1.9 billion. Five Prime shares were halted for news until 9 a.m.
businesswire.com Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash THOUSAND OAKS, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing…
businesswire.com Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash THOUSAND OAKS, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH
zacks.com Five Prime Therapeutics (FPRX) Expected to Beat Earnings Estimates: Should You Buy? Five Prime Therapeutics (FPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
businesswire.com Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (NASDAQ: FPRX), will report its fourth quarter and full year 2020 operational and financial results on Wednesday, March 10,…
benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET Thursday, 371 stocks hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Wednesday During Wednesday's morning trading, 472 companies set new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 67 companies set new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Monday On Monday, 61 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com Stocks That Hit 52-Week Lows On Friday
benzinga.com Stocks That Hit 52-Week Lows On Wednesday 
benzinga.com 78 Biggest Movers From Yesterday 
benzinga.com 51 Stocks Moving In Wednesday's Mid-Day Session - benzinga.com 40 Stocks Moving In Monday's Mid-Day Session
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday
benzinga.com New 52-Week Lows For Monday Morning - benzinga.com List of Companies Reaching Yearly Lows Tuesday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 29th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, September 11th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 16th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 15th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 14th
benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 9th - benzinga.com Stocks Which Set New 52-Week Low Yesterday, July 30th
- benzinga.com Stocks Which Set New 52-Week Low Friday, July 27
- benzinga.com 56 Biggest Movers From Yesterday